Latest news
Loading news…
ALX Oncology
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Francisco, California, United States Founded 2015 51-100 employees For Profit
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
ALX Oncology on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$348.2M
Funding Rounds
6
Last Funding
Acquisitions
1
Monthly Visits
Contacts
61
Ticker
ALXO
NASDAQ
Patents
2
About ALX Oncology
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ALXO
- Exchange
- NASDAQ
- IPO date
- Jul 16, 2020
- Raised at IPO
- $161.5M
- Valuation at IPO
- $668.8M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
- Active products
- 17
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $339.42K
Company Info
- Founded
- 2015
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 155
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Jul 16, 2020
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.4
- Trend (30d)
- 5
- Trend (90d)
- 6.5
- Last leadership hire
- Apr 13, 2026
- Last layoff mention
- Mar 5, 2025
ALX Oncology Funding Rounds
6 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 6Show
Page 1 / 2
ALX Oncology Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| ScalmiBio | $4.5M | 2021-10-07 | ALX Oncology | BiotechnologyLife ScienceOncology | United States |
1–1 of 1Show
Page 1 / 1
ALX Oncology Key People
Chief Executive Officer
President, Chief Executive Officer and Co-Founder
Chief Medical Officer
Chief Operating Officer
Chief Development and Operating Officer
Chief Financial Officer
61
professional contacts at ALX Oncology
Contact execs at ALX Oncology →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about ALX Oncology
People who checked this page also checked these
Sectors ALX Oncology invests & acquires in
Browse the full Acquirezy directory.